Inhibitors of myelination: ECM changes, CSPGs and PTPs

Experimental Neurology

Volumn 251, Issue , 2014, Pages 39-46

  Harlow, Danielle E ^a   Macklin, Wendy B ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATASE; PROTEOCHONDROITIN SULFATE; RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGMA; RHO KINASE; SCLEROPROTEIN; UNCLASSIFIED DRUG;

DEMYELINATION; EXTRACELLULAR MATRIX; HUMAN; MYELINATION; NERVE CELL DIFFERENTIATION; NONHUMAN; NOTE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REMYELINIZATION;

EID: 84888037068     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.10.017     Document Type: Note

References (168)

1. Aricescu A.R., McKinnell I.W., Halfter W., Stoker A.W. Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma. Mol. Cell. Biol. 2002, 22:1881-1892.
2. Back S.A., Tuohy T.M.F., Chen H., Wallingford N., Craig A., Struve J., Luo N.L., Banine F., Liu Y., Chang A., Trapp B.D., Bebo B.F., Rao M.S., Sherman L.S. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat. Med. 2005, 11:966-972.
3. Bandtlow C.E., Zimmermann D.R. Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol. Rev. 2000, 80:1267-1290.
4. Bannerman P., Hahn A., Soulika A., Gallo V., Pleasure D. Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia. Glia 2006, 55:57-64.
5. Barnett S.C., Linington C. Myelination: do astrocytes play a role?. Neuroscientist 2013, 19(5):442-450. 10.1177/1073858412465655.
6. Barritt A.W., Davies M., Marchand F., Hartley R., Grist J., Yip P., McMahon S.B., Bradbury E.J. Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J. Neurosci. 2006, 26:10856-10867.
7. Bekku Y., Rauch U., Ninomiya Y., Oohashi T. Brevican distinctively assembles extracellular components at the large diameter nodes of Ranvier in the CNS. J. Neurochem. 2009, 108:1266-1276.
8. Bradbury E.J., Carter L.M. Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res. Bull. 2011, 84:306-316.
9. Bradbury E.J., Moon L.D.F., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416:636-640.
10. Busch S.A., Silver J. The role of extracellular matrix in CNS regeneration. Curr. Opin. Neurobiol. 2007, 17:120-127.
11. Buttery P.C., ffrench-Constant C. Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes. Mol. Cell. Neurosci. 1999, 14:199-212.
12. Carbonetto S. The extracellular matrix of the nervous system. Trends Neurosci. 1984, 7:382-387.
13. Carbonetto S., Gruver M.M., Turner D.C. Nerve fiber growth in culture on fibronectin, collagen, and glycosaminoglycan substrates. J. Neurosci. 1983, 3:2324-2335.
14. Carmichael S.T., Archibeque I., Luke L., Nolan T., Momiy J., Li S. Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex. Exp. Neurol. 2005, 193:291-311.
15. Castillo G.M., Cummings J.A., Yang W., Judge M.E., Sheardown M.J., Rimvall K., Hansen J.B., Snow A.D. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes 1998, 47:612-620.
16. Chang A., Nishiyama A., Peterson J., Prineas J., Trapp B.D. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J. Neurosci. 2000, 20:6404-6412.
17. Chang A., Tourtellotte W.W., Rudick R., Trapp B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 2002, 346:165-173.
18. Chang A., Staugaitis S.M., Dutta R., Batt C.E., Easley K.E., Chomyk A.M., Yong V.W., Fox R.J., Kidd G.J., Trapp B.D. Cortical remyelination: a new target for repair therapies in multiple sclerosis. Ann. Neurol. 2012, 72:918-926.
19. Chen Z.J., Ughrin Y., Levine J.M. Inhibition of axon growth by oligodendrocyte precursor cells. Mol. Cell. Neurosci. 2002, 20:125-139.
20. Chesini I.M., Debyser G., Croes H., Ten Dam G.B., Devreese B., Stoker A.W., Hendriks W.J.A.J. PTPBR7 binding proteins in myelinating neurons of the mouse brain. Int. J. Biol. Sci. 2011, 7:978-991.
21. Coles C.H., Shen Y., Tenney A.P., Siebold C., Sutton G.C., Lu W., Gallagher J.T., Jones E.Y., Flanagan J.G., Aricescu A.R. Proteoglycan-specific molecular switch for RPTPσ clustering and neuronal extension. Science 2011, 332:484-488.
22. Crespo D., Asher R.A., Lin R., Rhodes K.E., Fawcett J.W. How does chondroitinase promote functional recovery in the damaged CNS?. Exp. Neurol. 2007, 206:159-171.
23. Czopka T., Holst von A., Schmidt G., ffrench-Constant C., Faissner A. Tenascin C and tenascin R similarly prevent the formation of myelin membranes in a RhoA-dependent manner, but antagonistically regulate the expression of myelin basic protein via a separate pathway. Glia 2009, 57:1790-1801.
24. Davies S.J.A., Goucher D.R., Doller C., Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J. Neurosci. 1999, 19:5810-5822.
25. Davies J.E., Tang X., Denning J.W., Archibald S.J., Davies S.J.A. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries. Eur. J. Neurosci. 2004, 19:1226-1242.
26. Deguchi K., Takaishi M., Hayashi T., Oohira A., Nagotani S., Li F., Jin G., Nagano I., Shoji M., Miyazaki M., Abe K., Huh N.-H. Expression of neurocan after transient middle cerebral artery occlusion in adult rat brain. Brain Res. 2005, 1037:194-199.
27. Denic A., Johnson A.J., Bieber A.J., Warrington A.E., Rodriguez M., Pirko I. The relevance of animal models in multiple sclerosis research. Pathophysiology 2011, 18:21-29.
28. DeWitt D.A., Silver J., Canning D.R., Perry G. Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease. Exp. Neurol. 1993, 121:149-152.
29. DeWitt D.A., Richey P.L., Praprotnik D., Silver J., Perry G. Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases. Brain Res. 1994, 656:205-209.
30. Dickendesher T.L., Baldwin K.T., Mironova Y.A., Koriyama Y., Raiker S.J., Askew K.L., Wood A., Geoffroy C.G., Zheng B., Liepmann C.D., Katagiri Y., Benowitz L.I., Geller H.M., Giger R.J. NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. Nat. Publ. Group 2012, 15:703-712.
31. Fancy S.P.J., Harrington E.P., Yuen T.J., Silbereis J.C., Zhao C., Baranzini S.E., Bruce C.C., Otero J.J., Huang E.J., Nusse R., Franklin R.J.M., Rowitch D.H. Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat. Neurosci. 2011, 14:1009-1016.
32. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., Sofroniew M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 2004, 24:2143-2155.
33. Fisher D., Xing B., Dill J., Li H., Hoang H.H., Zhao Z., Yang X.-L., Bachoo R., Cannon S., Longo F.M., Sheng M., Silver J., Li S. Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. J. Neurosci. 2011, 31:14051-14066.
34. Fitch M.T., Silver J. Glial cell extracellular matrix: boundaries for axon growth in development and regeneration. Cell Tissue Res. 1997, 290:379-384.
35. Fitch M.T., Silver J. CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp. Neurol. 2008, 209:294-301.
36. Franco S.J., Müller U. Extracellular matrix functions during neuronal migration and lamination in the mammalian central nervous system. Dev. Neurobiol. 2011, 71:889-900.
37. Franklin R.J.M. Why does remyelination fail in multiple sclerosis?. Nat. Rev. Neurosci. 2002, 3:705-714.
38. Franklin R.J.M., Crang A.J., Blakemore W.F. Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord. J. Neurocytol. 1991, 20:420-430.
39. Franklin R.J.M., Bayley S.A., Blakemore W.F. Transplanted CG4 cells (an oligodendrocyte progenitor cell line) survive, migrate, and contribute to repair of areas of demyelination in X-irradiated and damaged spinal cord but not in normal spinal cord. Exp. Neurol. 1996, 137:263-276.
40. Fry E.J., Chagnon M.J., López-Vales R., Tremblay M.L., David S. Corticospinal tract regeneration after spinal cord injury in receptor protein tyrosine phosphatase sigma deficient mice. Glia 2010, 58:423-433.
41. Galtrey C.M., Fawcett J.W. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res. Rev. 2007, 54:1-18.
42. Galtrey C.M., Kwok J.C.F., Carulli D., Rhodes K.E., Fawcett J.W. Distribution and synthesis of extracellular matrix proteoglycans, hyaluronan, link proteins and tenascin-R in the rat spinal cord. Eur. J. Neurosci. 2008, 27:1373-1390.
43. Gama C.I., Tully S.E., Sotogaku N., Clark P.M., Rawat M., Vaidehi N., Goddard W.A., Nishi A., Hsieh-Wilson L.C. Sulfation patterns of glycosaminoglycans encode molecular recognition and activity. Nat. Chem. Biol. 2006, 2:467-473.
44. Garcion E., Faissner A., ffrench-Constant C. Knockout mice reveal a contribution of the extracellular matrix molecule tenascin-C to neural precursor proliferation and migration. Development 2001, 128:2485-2496.
45. Garwood J., Schnädelbach O., Clement A., Schütte K., Bach A., Faissner A. DSD-1-proteoglycan is the mouse homolog of phosphacan and displays opposing effects on neurite outgrowth dependent on neuronal lineage. J. Neurosci. 1999, 19:3888-3899.
46. Garwood J., Garcion E., Dobbertin A., Heck N., Calco V., ffrench-Constant C., Faissner A. The extracellular matrix glycoprotein tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor. Eur. J. Neurosci. 2004, 20:2524-2540.
47. Gordon M.K., Hahn R.A. Collagens. Cell Tissue Res. 2010, 339:247-257.
48. Gutowski N.J., Newcombe J., Cuzner M.L. Tenascin-R and C in multiple sclerosis lesions: relevance to extracellular matrix remodelling. Neuropathol. Appl. Neurobiol. 1999, 25:207-214.
49. Haist V., Ulrich R., Kalkuhl A., Deschl U., Baumgärtner W. Distinct spatio-temporal extracellular matrix accumulation within demyelinated spinal cord lesions in Theiler's murine encephalomyelitis. Brain Pathol. 2012, 22:188-204.
50. Hanemann C.O., Kuhn G., Lie A., Gillen C., Bosse F., Spreyer P., Müller H.W. Expression of decorin mRNA in the nervous system of rat. J. Histochem. Cytochem. 1993, 41:1383-1391.
51. Harrington E.P., Zhao C., Fancy S.P.J., Kaing S., Franklin R.J.M., Rowitch D.H. Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination. Ann. Neurol. 2010, 68:703-716.
52. Harroch S., Furtado G.C., Brueck W., Rosenbluth J., Lafaille J., Chao M., Buxbaum J.D., Schlessinger J. A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions. Nat. Genet. 2002, 32:411-414.
53. Haylock-Jacobs S., Keough M.B., Lau L., Yong V.W. Chondroitin sulphate proteoglycans: extracellular matrix proteins that regulate immunity of the central nervous system. Autoimmun. Rev. 2011, 10:766-772.
54. Holley J.E., Gveric D., Whatmore J.L., Gutowski N.J. Tenascin C induces a quiescent phenotype in cultured adult human astrocytes. Glia 2005, 52:53-58.
55. Horn K.E., Xu B., Gobert D., Hamam B.N., Thompson K.M., Wu C.-L., Bouchard J.-F., Uetani N., Racine R.J., Tremblay M.L., Ruthazer E.S., Chapman C.A., Kennedy T.E. Receptor protein tyrosine phosphatase sigma regulates synapse structure, function and plasticity. J. Neurochem. 2012, 122:147-161.
56. Hossain-Ibrahim M.K., Rezajooi K., Stallcup W.B., Lieberman A.R., Anderson P.N. Analysis of axonal regeneration in the central and peripheral nervous systems of the NG2-deficient mouse. BMC Neurosci. 2007, 8:80.
57. Hu J., Deng L., Wang X., Xu X.M. Effects of extracellular matrix molecules on the growth properties of oligodendrocyte progenitor cells in vitro. J. Neurosci. Res. 2009, 87:2854-2862.
58. Huang W.-C., Kuo W.-C., Cherng J.-H., Hsu S.-H., Chen P.-R., Huang S.-H., Huang M.-C., Liu J.-C., Cheng H. Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury. Biochem. Biophys. Res. Commun. 2006, 349:963-968.
59. Iaci J.F., Vecchione A.M., Zimber M.P., Caggiano A.O. Chondroitin sulfate proteoglycans in spinal cord contusion injury and the effects of chondroitinase treatment. J. Neurotrauma 2007, 24:1743-1759.
60. Inatani M., Honjo M., Otori Y., Oohira A., Kido N., Tano Y., Honda Y., Tanihara H. Inhibitory effects of neurocan and phosphacan on neurite outgrowth from retinal ganglion cells in culture. Invest. Ophthalmol. Vis. Sci. 2001, 42:1930-1938.
61. Jones T.R., Ruoslahti E., Schold S.C., Bigner D.D. Fibronectin and glial fibrillary acidic protein expression in normal human brain and anaplastic human gliomas. Cancer Res. 1982, 42:168-177.
62. Jones L.L., Yamaguchi Y., Stallcup W.B., Tuszynski M.H. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J. Neurosci. 2002, 22:2792-2803.
63. Jones L.L., Sajed D., Tuszynski M.H. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition. J. Neurosci. 2003, 23:9276-9288.
64. Kappler J., Stichel C.C., Gleichmann M., Gillen C., Junghans U., Kresse H., Müller H.W. Developmental regulation of decorin expression in postnatal rat brain. Brain Res. 1998, 793:328-332.
65. Karimi-Abdolrezaee S., Schut D., Wang J., Fehlings M.G. Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury. PLoS ONE 2012, 7:e37589.
66. Kawczak J.A., Mathisen P.M., Drazba J.A., Fuss B., Macklin W.B., Tuohy V.K. Digitized image analysis reveals diffuse abnormalities in normal-appearing white matter during acute experimental autoimmune encephalomyelitis. J. Neurosci. Res. 1998, 54:364-372.
67. Kiernan B.W., Götz B., Faissner A., ffrench-Constant C. Tenascin-C inhibits oligodendrocyte precursor cell migration by both adhesion-dependent and adhesion-independent mechanisms. Mol. Cell. Neurosci. 1996, 7:322-335.
68. Kotter M.R., Setzu A., Sim F.J., Van Rooijen N., Franklin R.J. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 2001, 35:204-212.
69. Kuboyama K., Fujikawa A., Masumura M., Suzuki R., Matsumoto M., Noda M. Protein tyrosine phosphatase receptor type z negatively regulates oligodendrocyte differentiation and myelination. PLoS ONE 2012, 7:e48797.
70. Kurazono S., Okamoto M., Sakiyama J., Mori S., Nakata Y., Fukuoka J., Amano S., Oohira A., Matsui H. Expression of brain specific chondroitin sulfate proteoglycans, neurocan and phosphacan, in the developing and adult hippocampus of Ihara's epileptic rats. Brain Res. 2001, 898:36-48.
71. Kwok J.C.F., Warren P., Fawcett J.W. Chondroitin sulfate: a key molecule in the brain matrix. Int. J. Biochem. Cell Biol. 2012, 44:582-586.
72. Laabs T.L., Wang H., Katagiri Y., McCann T., Fawcett J.W., Geller H.M. Inhibiting glycosaminoglycan chain polymerization decreases the inhibitory activity of astrocyte-derived chondroitin sulfate proteoglycans. J. Neurosci. 2007, 27:14494-14501.
73. Lamprianou S., Harroch S. Receptor protein tyrosine phosphatase from stem cells to mature glial cells of the central nervous system. JMN 2006, 29:241-255.
74. Lamprianou S., Chatzopoulou E., Thomas J.-L., Bouyain S., Harroch S. A complex between contactin-1 and the protein tyrosine phosphatase PTPRZ controls the development of oligodendrocyte precursor cells. Proc. Natl. Acad. Sci. 2011, 108:17498-17503.
75. Lau L.W., Keough M.B., Haylock-Jacobs S., Cua R., Döring A., Sloka S., Stirling D.P., Rivest S., Yong V.W. Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. Ann. Neurol. 2012, 72:419-432.
76. Lemons M.L., Howland D.R., Anderson D.K. Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation. Exp. Neurol. 1999, 160:51-65.
77. Liberto C.M., Albrecht P.J., Herx L.M., Yong V.W., Levison S.W. Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 2004, 89:1092-1100.
78. Liesi P., Kaakkola S., Dahl D., Vaheri A. Laminin is induced in astrocytes of adult brain by injury. EMBO J. 1984, 3:683-686.
79. Liu B.P., Cafferty W.B.J., Budel S.O., Strittmatter S.M. Extracellular regulators of axonal growth in the adult central nervous system. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2006, 361:1593-1610.
80. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002, 8:500-508.
81. Lundell A., Olin A.I., Mörgelin M., al-Karadaghi S., Aspberg A., Logan D.T. Structural basis for interactions between tenascins and lectican C-type lectin domains: evidence for a crosslinking role for tenascins. Structure 2004, 12:1495-1506.
82. Mann M.K., Ray A., Basu S., Karp C.L., Dittel B.N. Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis. Autoimmunity 2012, 45:388-399.
83. Martin K.R., Narang P., Xu Y., Kauffman A.L., Petit J., Xu H.E., Meurice N., MacKeigan J.P. Identification of small molecule inhibitors of PTPσ through an integrative virtual and biochemical approach. PLoS ONE 2012, 7:e50217.
84. Massa P.T., Ropka S.L., Saha S., Fecenko K.L., Beuler K.L. Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus. J. Virol. 2002, 76:8335-8346.
85. Massey J.M., Amps J., Viapiano M.S., Matthews R.T., Wagoner M.R., Whitaker C.M., Alilain W., Yonkof A.L., Khalyfa A., Cooper N.G.F., Silver J., Onifer S.M. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp. Neurol. 2008, 209:426-445.
86. Mattila E., Pellinen T., Nevo J., Vuoriluoto K., Arjonen A., Ivaska J. Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP. Nat. Cell Biol. 2005, 7:78-85.
87. Maurel P., Rauch U., Flad M., Margolis R.K., Margolis R.U. Phosphacan, a chondroitin sulfate proteoglycan of brain that interacts with neurons and neural cell-adhesion molecules, is an extracellular variant of a receptor-type protein tyrosine phosphatase. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2512-2516.
88. McClain C.R., Sim F.J., Goldman S.A. Pleiotrophin suppression of receptor protein tyrosine phosphatase-β/ζ maintains the self-renewal competence of fetal human oligodendrocyte progenitor cells. J. Neurosci. 2012, 32:15066-15075.
89. McTigue D.M., Wei P., Stokes B.T. Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J. Neurosci. 2001, 21:3392-3400.
90. McTigue D.M., Tripathi R., Wei P. NG2 colocalizes with axons and is expressed by a mixed cell population in spinal cord lesions. J. Neuropathol. Exp. Neurol. 2006, 65:406-420.
91. Milner R., Edwards G., Streuli C., ffrench-Constant C. A role in migration for the alpha V beta 1 integrin expressed on oligodendrocyte precursors. J. Neurosci. 1996, 16:7240-7252.
92. Mohan H., Krumbholz M., Sharma R. extracellular matrix in multiple sclerosis lesions: fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells - Mohan - 2010 - brain pathology - Wiley online library. Brain 2010, 20(5):966-975. 10.1111/j.1750-3639.2010.00399.xc.
93. Morgenstern D.A., Asher R.A., Fawcett J.W. Chondroitin sulphate proteoglycans in the CNS injury response. Prog. Brain Res. 2002, 137:313-332.
94. Muja N., Lovas G., Romm E., Machleder D., Ranjan M., Gallo V., Hudson L.D. Expression of a catalytically inactive transmembrane protein tyrosine phosphatase epsilon (tm-PTP epsilon) delays optic nerve myelination. Glia 2004, 48:278-297.
95. Nait-Oumesmar B., Decker L., Lachapelle F., Avellana-Adalid V., Bachelin C., Van Evercooren A.B. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur. J. Neurosci. 1999, 11:4357-4366.
96. Nakanishi K., Aono S., Hirano K., Kuroda Y., Ida M., Tokita Y., Matsui F., Oohira A. Identification of neurite outgrowth-promoting domains of neuroglycan C, a brain-specific chondroitin sulfate proteoglycan, and involvement of phosphatidylinositol 3-kinase and protein kinase C signaling pathways in neuritogenesis. J. Biol. Chem. 2006, 281:24970-24978.
97. Nash B., Ioannidou K., Barnett S.C. Astrocyte phenotypes and their relationship to myelination. J. Anat. 2010, 219:44-52.
98. Niehaus A., Stegmüller J., Diers-Fenger M., Trotter J. Cell-surface glycoprotein of oligodendrocyte progenitors involved in migration. J. Neurosci. 1999, 19:4948-4961.
99. Nishiyama A., Chang A., Trapp B.D. NG2+ glial cells: a novel glial cell population in the adult brain. J. Neuropathol. Exp. Neurol. 1999, 58:1113-1124.
100. Ogawa T., Hagihara K., Suzuki M., Yamaguchi Y. Brevican in the developing hippocampal fimbria: differential expression in myelinating oligodendrocytes and adult astrocytes suggests a dual role for brevican in central nervous system fiber tract development. J. Comp. Neurol. 2001, 432:285-295.
101. Okamoto M., Sakiyama J., Mori S., Kurazono S., Usui S., Hasegawa M., Oohira A. Kainic acid-induced convulsions cause prolonged changes in the chondroitin sulfate proteoglycans neurocan and phosphacan in the limbic structures. Exp. Neurol. 2003, 184:179-195.
102. Ozerdem U., Grako K.A., Dahlin-Huppe K., Monosov E., Stallcup W.B. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev. Dyn. 2001, 222:218-227.
103. Pallen C. Protein tyrosine phosphatase sigma; PTP sigma: a Src family kinase activator and mediator of multiple biological effects. CTMC 2003, 3:821-835.
104. Pearlman A.L., Sheppard A.M. Extracellular matrix in early cortical development. Prog. Brain Res. 1996, 108:117-134.
105. Pendleton J.C., Shamblott M.J., Gary D.S., Belegu V., Hurtado A., Malone M.L., McDonald J.W. Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPσ. Exp. Neurol. 2013, 247C:113-121.
106. Pesheva P., Probstmeier R. The yin and yang of tenascin-R in CNS development and pathology. Prog. Neurobiol. 2000, 61:465-493.
107. Pesheva P., Spiess E., Schachner M. J1-160 and J1-180 are oligodendrocyte-secreted nonpermissive substrates for cell adhesion. J. Cell Biol. 1989, 109:1765-1778.
108. Properzi F., Asher R.A., Fawcett J.W. Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury. Biochem. Soc. Trans. 2003, 31:335-336.
109. Raine C.S., Wu E. Multiple sclerosis: remyelination in acute lesions. J. Neuropathol. Exp. Neurol. 1993, 52:199-204.
110. Ranjan M., Hudson L.D. Regulation of tyrosine phosphorylation and protein tyrosine phosphatases during oligodendrocyte differentiation. Mol. Cell. Neurosci. 1996, 7:404-418.
111. Rhodes K.E., Fawcett J.W. Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?. J. Anat. 2004, 204:33-48.
112. Rhodes K.E., Raivich G., Fawcett J.W. The injury response of oligodendrocyte precursor cells is induced by platelets, macrophages and inflammation-associated cytokines. NSC 2006, 140:87-100.
113. Rutka James T., Apodaca Gerard, Stern Robert, Rosenblum Mark The extracellular matrix of the central and peripheral nervous systems: structure and function 1988, 10.3171/jns.1988.69.2.0155.
114. Sajad M., Zargan J., Chawla R., Umar S., Khan H.A. Upregulation of CSPG3 accompanies neuronal progenitor proliferation and migration in EAE. J. Mol. Neurosci. 2011, 43:531-540.
115. Salcedo R., Patarroyo M. Constitutive alpha V beta 3 integrin-mediated adhesion of human lymphoid B cells to vitronectin substrate. Cell. Immunol. 1995, 160:165-172.
116. Sandvig A., Berry M., Barrett L.B., Butt A., Logan A. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 2004, 46:225-251.
117. Sanes J.R. Extracellular matrix molecules that influence neural development. Annu. Rev. Neurosci. 1989, 12:491-516.
118. Schaefer L., Schaefer R.M. Proteoglycans: from structural compounds to signaling molecules. Cell Tissue Res. 2010, 339:237-246.
119. Schlessinger J., Lax I., Lemmon M. Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?. Cell 1995, 83:357-360.
120. Schmalfeldt M., Dours-Zimmermann M.T., Winterhalter K.H., Zimmermann D.R. Versican V2 is a major extracellular matrix component of the mature bovine brain. J. Biol. Chem. 1998, 273:15758-15764.
121. Schmalfeldt M., Bandtlow C.E., Dours-Zimmermann M.T., Winterhalter K.H., Zimmermann D.R. Brain derived versican V2 is a potent inhibitor of axonal growth. J. Cell Sci. 2000, 113(Pt 5):807-816.
122. Schneider S., Bosse F., D'Urso D., Muller H., Sereda M.W., Nave K.-A.A., Niehaus A., Kempf T., Schnolzer M., Trotter J. The AN2 protein is a novel marker for the Schwann cell lineage expressed by immature and nonmyelinating Schwann cells. J. Neurosci. 2001, 21:920-933.
123. Schonberg D.L., Popovich P.G., McTigue D.M. Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation. J. Neuropathol. Exp. Neurol. 2007, 66:1124-1135.
124. Schwartz N.B., Domowicz M. Proteoglycans in brain development. Glycoconj. J. 2004, 21:329-341.
125. Sharma K., Selzer M.E., Li S. Scar-mediated inhibition and CSPG receptors in the CNS. Exp. Neurol. 2012, 237:370-378.
126. Shen Y., Tenney A.P., Busch S.A., Horn K.P., Cuascut F.X., Liu K., He Z., Silver J., Flanagan J.G. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 2009, 326:592-596.
127. Sherman L.S., Back S.A. A "GAG" reflex prevents repair of the damaged CNS. Trends Neurosci. 2008, 31:44-52.
128. Shibayama H., Tagawa S., Hattori H., Inoue R., Katagiri S., Kitani T. Laminin and fibronectin promote the chemotaxis of human malignant plasma cell lines. Blood 1995, 86:719-725.
129. Shields S.A., Blakemore W.F., Franklin R.J.M. Schwann cell remyelination is restricted to astrocyte-deficient areas after transplantation into demyelinated adult rat brain. J. Neurosci. Res. 2000, 60:571-578.
130. Siebert J.R., Osterhout D.J. The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes. J. Neurochem. 2011, 119:176-188.
131. Siebert J.R., Stelzner D.J., Osterhout D.J. Chondroitinase treatment following spinal contusion injury increases migration of oligodendrocyte progenitor cells. Exp. Neurol. 2011, 231:19-29.
132. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
133. Sirko S., von Holst A., Weber A., Wizenmann A., Theocharidis U., Götz M., Faissner A. Chondroitin sulfates are required for fibroblast growth factor-2-dependent proliferation and maintenance in neural stem cells and for epidermal growth factor-dependent migration of their progeny. Stem Cells 2010, 28:775-787.
134. Skihar V., Silva C., Chojnacki A., Döring A., Stallcup W.B., Weiss S., Yong V.W. Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate. Proc. Natl. Acad. Sci. 2009, 106:17992-17997.
135. Sloane J.A., Batt C., Ma Y., Harris Z.M., Trapp B.D., Vartanian T. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc. Natl. Acad. Sci. 2010, 107:11555-11560.
136. Snow A.D., Mar H., Nochlin D., Kimata K., Kato M., Suzuki S., Hassell J., Wight T.N. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 1988, 133:456-463.
137. Snow A.D., Mar H., Nochlin D., Sekiguchi R.T., Kimata K., Koike Y., Wight T.N. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Pathol. 1990, 137:1253-1270.
138. Sobel R.A. The extracellular matrix in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 1998, 57:205.
139. Sobel R.A. The extracellular matrix in multiple sclerosis: an update. Braz. J. Med. Biol. Res. 2001, 34:603-609.
140. Sobel R.A., Ahmed A.S. White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis. J. Neuropathol. Exp. Neurol. 2001, 60:1198-1207.
141. Sobel R.A., Mitchell M.E. Fibronectin in multiple sclerosis lesions. Am. J. Pathol. 1989, 135:161-168.
142. Sobel R.A., Chen M., Maeda A., Hinojoza J.R. Vitronectin and integrin vitronectin receptor localization in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 1995, 54:202-213.
143. Soleman S., Yip P.K., Duricki D.A., Moon L.D.F. Delayed treatment with chondroitinase ABC promotes sensorimotor recovery and plasticity after stroke in aged rats. Brain 2012, 135:1210-1223.
144. Starkey M.L., Bartus K., Barritt A.W., Bradbury E.J. Chondroitinase ABC promotes compensatory sprouting of the intact corticospinal tract and recovery of forelimb function following unilateral pyramidotomy in adult mice. Eur. J. Neurosci. 2012, 36:3665-3678.
145. Stoffels J.M.J., de Jonge J.C., Stancic M., Nomden A., van Strien M.E., Ma D., Šišková Z., Maier O., ffrench-Constant C., Franklin R.J.M., Hoekstra D., Zhao C., Baron W. Fibronectin aggregation in multiple sclerosis lesions impairs remyelination. Brain 2013, 136:116-131.
146. Talbott J.F., Loy D.N., Liu Y., Qiu M.S., Bunge M.B., Rao M.S., Whittemore S.R. Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Exp. Neurol. 2005, 192:11-24.
147. Tan A.M., Zhang W., Levine J.M. NG2: a component of the glial scar that inhibits axon growth. J. Anat. 2005, 207:717-725.
148. Tan A.M., Colletti M., Rorai A.T., Skene J.H.P., Levine J.M. Antibodies against the NG2 proteoglycan promote the regeneration of sensory axons within the dorsal columns of the spinal cord. J. Neurosci. 2006, 26:4729-4739.
149. Tang X., Davies J.E., Davies S.J.A. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J. Neurosci. Res. 2003, 71:427-444.
150. Tester N.J., Howland D.R. Chondroitinase ABC improves basic and skilled locomotion in spinal cord injured cats. Exp. Neurol. 2008, 209:483-496.
151. Tripathi R., McTigue D.M. Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia 2007, 55:698-711.
152. Turner D.C., Flier L.A., Carbonetto S. Identification of a cell-surface protein involved in PC12 cell-substratum adhesion and neurite outgrowth on laminin and collagen. J. Neurosci. 1989, 9:3287-3296.
153. Ulrich J., Bornstein M.B. Experimental allergic encephalomyelitis (EAE): delayed myelination-inhibition in vitro with EAE-serum: changes in vulnerability of oligodendroglia and newly formed myelin sheaths. Acta Neuropathol. 1973, 25:138-148.
154. van Horssen J., Bø L., Dijkstra C.D., de Vries H.E. Extensive extracellular matrix depositions in active multiple sclerosis lesions. Neurobiol. Dis. 2006, 24:484-491.
155. Verna J.M., Fichard A., Saxod R. Influence of glycosaminoglycans on neurite morphology and outgrowth patterns in vitro. Int. J. Dev. Neurosci. 1989, 7:389-399.
156. Villanova M., Sewry C., Malandrini A., Toti P., Muntoni F., Merlini L., Torelli S., Tosi P., Maraldi N.M., Guazzi G.C. Immunolocalization of several laminin chains in the normal human central and peripheral nervous system. J. Submicrosc. Cytol. Pathol. 1997, 29:409-413.
157. Wang P.-S., Wang J., Xiao Z.-C., Pallen C.J. Protein-tyrosine phosphatase alpha acts as an upstream regulator of Fyn signaling to promote oligodendrocyte differentiation and myelination. J. Biol. Chem. 2009, 284:33692-33702.
158. Wang P.-S., Wang J., Zheng Y., Pallen C.J. Loss of protein-tyrosine phosphatase α (PTPα) increases proliferation and delays maturation of oligodendrocyte progenitor cells. J. Biol. Chem. 2012, 287:12529-12540.
159. Watkins T.A., Emery Ben, Mulinyawe S., Barres B.A. Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron 2008, 60:555-569.
160. Williams A., Piaton G., Lubetzki C. Astrocytes-friends or foes in multiple sclerosis?. Glia 2007, 55:1300-1312.
161. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell. Mol. Life Sci. 2000, 57:276-289.
162. Yang Z., Suzuki R., Daniels S.B., Brunquell C.B., Sala C.J., Nishiyama A. NG2 glial cells provide a favorable substrate for growing axons. J. Neurosci. 2006, 26:3829-3839.
163. Yiu G., He Z. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. 2006, 7:617-627.
164. Yurchenco P.D., Cheng Y.S., Colognato H. Laminin forms an independent network in basement membranes. J. Cell Biol. 1992, 117:1119-1133.
165. Zhao C., Fancy S.P.J., ffrench-Constant C., Franklin R.J.M. Osteopontin is extensively expressed by macrophages following CNS demyelination but has a redundant role in remyelination. Neurobiol. Dis. 2008, 31:209-217.
166. Zhao C., Fancy S.P.J., Franklin R.J.M., ffrench-Constant C. Up-regulation of oligodendrocyte precursor cell alphaV integrin and its extracellular ligands during central nervous system remyelination. J. Neurosci. Res. 2009, 87:3447-3455.
167. Zhou J., Nagarkatti P., Zhong Y., Nagarkatti M. Immune modulation by chondroitin sulfate and its degraded disaccharide product in the development of an experimental model of multiple sclerosis. J. Neuroimmunol. 2010, 223:55-64.
168. Zimmermann D.R., Dours-Zimmermann M.T. Extracellular matrix of the central nervous system: from neglect to challenge 2008, 130:635-653.